Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
Saved in:
| Title: | Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. |
|---|---|
| Authors: | Rothenberg ML; University of Texas Health Science Center at San Antonio, USA. mace.rothenberg@mcmail.vanderbilt.edu, Sharma A, Weiss GR, Villalona-Calero MA, Eckardt JR, Aylesworth C, Kraynak MA, Rinaldi DA, Rodriguez GI, Burris HA 3rd, Eckhardt SG, Stephens CD, Forral K, Nicol SJ, Von Hoff DD |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1998 Jul; Vol. 9 (7), pp. 733-8. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Print ISSN: 0923-7534 (Print) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
